At ITRT we are pioneers in the development of advanced cell therapy medicines.
As international leaders in regulated regenerative medicine, we work with cultured mesenchymal cells (CMC) in therapies supported by scientific evidence and individualized authorization by the AEMPS (Spanish Agency of Medicines and Medical Devices).
We manufacture each personalized cell dose in a GMP cleanroom, adapted to the clinical diagnosis of each patient, and administer it in a hospital environment, under controlled conditions and regulated clinical follow-up.
More than 20 years leading clinical research in advanced cell therapies
Since the first clinical trial with cultured mesenchymal cells in 2002, ITRT has developed a therapeutic model based on evidence, personalization, and regulatory compliance.
Our trajectory reflects a continuous evolution towards safer, more effective, and fully regulated treatments.
2017
2017
Clinical trial in Lumbar Disc Degeneration (international and multicenter) – RESPINE
Clinical trial in Knee Osteoarthritis (national and multicenter) – ARTROCELL
2014
2014
Clinical trial in Pseudarthrosis with allogeneic adipose tissue (national and multicenter)
2012
2012
Clinical trial in Knee Osteoarthritis with cryopreserved cells
Clinical trial in Knee Osteoarthritis with allogeneic cells (national and multicenter)
2009
2009
Clinical trial in Lumbar Disc Degeneration
Clinical trial in Knee Osteoarthritis grade II–III (Xcelia)
Clinical trial in Knee Osteoarthritis grade II–IV (IBGM)
2004
2004
Maxillary atrophy (pilot)
Regulatory change. Cell treatment considered a medicinal product controlled by the Spanish Agency of Medicines and Medical Devices (AEMPS).
Over 1,900 patients treated and 3,250 cell doses administered under controlled clinical conditions.
Experts in regulated and personalized cell therapies
Dr. Robert Soler, MD, PhD
Co-founder and Medical Director
Specialist in biological therapies with cultured mesenchymal cells
License No.: 08-26093
- Degree in Medicine and Surgery, Autonomous University of Barcelona
- Specialist in Rheumatology
- Postgraduate in Sports Traumatology, University Paul Sabatier, Toulouse
Dr. Lluís Orozco, MD, PhD
Co-founder and Scientific Director
Specialist in biological therapies with cultured mesenchymal cells
Orthopedic Surgery and Traumatology
License No.: 08-11337
- Degree in Medicine and Surgery, University of Navarra
- PhD in Medicine, “cum laude”, Autonomous University of Barcelona
- Specialist in Orthopedic Surgery and Traumatology
General Management
Dr.Robert Soler
CEO
Alejandra Jiménez
General Manager
Raquel Lazo
Deputy General Manager
A medical team committed to innovation and excellence
At ITRT we have a highly specialized medical and technical team, committed to clinical excellence, scientific rigor, and regulatory compliance.
Our professionals lead each stage of the treatment: from the manufacture of the cell-based medicine in a cleanroom to its personalized clinical administration and regulated follow-up.
Medical and Clinical Area
Dr. Anthony Barrios, MD
Family Medicine
License No.: 08-49553
Dr. Ignacio Muro, MD.
Sports Medicine Physician
License No.: 08-25600.
Dr. Ferran Corcoll, MD, PhD
Orthopedic Surgery and Traumatology
License No.: 08-52809
Dra. Rosanna Negre, MD
Aesthetic Medicine and Antiaging
License No.: 08-22077
Dr. David Vázquez, MD
Rheumatology
License No.: 08-32905
Dr. Jaume Vilaró, MD
Orthopedic Surgery and Traumatology
License No.: 08-19878
Operational Coordination and Strategic Management
Alejandra Jiménez
Clinical Management & Patient Relations
Raquel Lazo
Economic, Accounting & Administrative Management
Albert Serra
Marketing & Institutional Relations
Clinical Support and Patient Care
Sara Gavilán
Administrative Secretary
Laura Lloria
Clinical Secretary & Patient Management
Óscar Bascuñana
Clinical Nursing Management
Belén Mena
Clinical Secretary & Patient Management